ESC 365 - Closing remarks - New directions in antithrombotic management of high risk patients.

ESC Premium Access

Closing remarks - New directions in antithrombotic management of high risk patients.

Session: New directions in antithrombotic management of high risk patients

Topic: Treatment

Speaker: Professor M. Cowie (Cambridge, GB)

Sponsored by Bayer AG

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Martin Cowie

AstraZeneca, Cambridge (United Kingdom of Great Britain & Northern Ireland)

112 presentations

5 followers

3 more presentations in this session

Opening remarks - New directions in antithrombotic management of high risk patients.

Speaker: Professor M. Cowie (Cambridge, GB)

Heart failure in focus: results of COMMANDER-HF.

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Heart Failure in focus: clinical implications in light of the new scientific data;

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR) Professor M. Cowie (Cambridge, GB)

Access the full session

New directions in antithrombotic management of high risk patients

Speakers: Professor M. Cowie, Professor M. Cowie, Professor F. Zannad, Professor F. Zannad, Professor M. Cowie

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources